{"prompt": "['MEIRAGTX', 'Gene Therapy for Achromatopsia (CNGA3)', '2: Trial Assessments). We anticipate that that majority of participants will have no detectable pre-', 'existing circulating antibodies against AAV8. The presence or absence of circulating antibodies will not', 'affect recruitment of the participant. All serology tests will be performed at a laboratory approved by', 'the sponsor and their research development partners. There is wide variability in the abilities of', 'individual children to perform certain of the proposed investigations; the evaluations for children will', 'be restricted to those tests that individuals are able to perform reliably.', 'Tests that will be performed in all participants are:', 'Serological tests', 'Blood pressure', 'Haematology', 'Biochemistry', 'Ocular examination', 'Colour fundus photography', 'Spectral Domain Optical coherence tomography (SD-OCT)', 'Fundus Autofluorescence (FAF) imaging', 'Best corrected visual acuity', 'At least one of static perimetry and / or full-field stimulus testing.', 'Light-sensitivity (Photoaversion) testing', 'Tests that will be performed where possible unless lack of patient co-operation or equipment/', 'facilities are:', 'Contrast sensitivity', 'Reading assessment', 'Colour vision testing', 'Adaptive optics (AO) imaging', 'QOL questionnaires', 'Further details of clinical assessments can be found in the Gene Therapy for Achromatopsia (CNGA3)', 'study manual. Images taken at all timepoints will be sent for independent reading and analysis at', 'centres in both the UK and US.', '(i) Ocular examination and retinal imaging.', 'Ocular examination using slit lamp biomicroscopy will assess the anatomical integrity of the eyes and', 'allow quantification of intraocular inflammation. During the examination, intraocular pressure will be', 'determined by tonometry.', 'Retinal imaging includes colour fundus photography, fundus autofluorescence (FAF) imaging, SD-OCT,', 'and adaptive optics (AO) imaging. FAF imaging allows visualisation of the retinal pigment epithelium', '(RPE) by taking advantage of its intrinsic fluorescence derived from its lipofuscin content. SD-OCT', 'CNGA3 MGT012 Protocol version 6.0 16Apr2021', 'Page 36 of 68']['MEIRAGTx', 'Gene Therapy for Achromatopsia (CNGA3)', 'imaging enables measurement of retinal thickness and provides information about the integrity of the', 'layers of the retina. AO imaging provides direct visualization of the photoreceptor mosaics in vivo.', '(ii) Functional and Participant-Related Outcome Assessments.', 'Where possible the participant will complete an age appropriate Impact of Visual Impairment (IVI)', 'vision-specific quality of life questionnaire, and EQ5D-5L questionnaire and EQ5D-Y questionnaire, or', 'equivalent as appropriate. Reading ability including reading acuity, maximum reading rate, and critical', 'print size will be assessed where possible.', 'The degree of light sensitivity (photoaversion) will be investigated in two ways (i) Objectively by', 'measurement of palpebral aperture narrowing in response to gradually increasing light intensity and', '(ii) Subjectively by participant reported symptomatology.', 'Best-corrected ETDRS visual acuity will be measured in each eye. Contrast sensitivity will be measured', 'using the Pelli-Robson chart.', 'Colour vision will be assessed comprehensively using plate tests and computerised tests probing', 'colour discrimination along all 3 axes of colour.', 'Retinal sensitivity will be determined using static perimetry and/or full field stimulus testing (FST)', 'where possible.', 'Full-field electroretinography (ERG) and pattern ERG (PERG) will be performed according to the', 'International Society for Clinical Electrophysiology of Vision (ISCEV) standards to assess both', 'generalised retinal (rod and cone systems) and isolated macular function. Modified ISCEV protocols', 'may be necessary in young children using internationally recognised modified protocols. For young', 'children, this procedure may be performed under general anaesthesia.', 'ERG data will be analysed and interpreted by dedicated full-time Clinical Visual Electrophysiology', 'Consultants with extensive experience and who are directly involved in defining ISCEV standards.', '5.4.2.2 ATIMP administration Procedures', 'The protocol describes the intended surgical technique for ATIMP administration. The surgical', 'procedure may be modified on a case-by-case basis in the interests of safety; any modification will be', 'documented in the operation notes and eCRF. Consent to record the surgery will be requested of the', 'participant. Intraocular surgery will be recorded by video via the operating microscope as described', 'in the consent process. Relevant anonymised video recordings and images will be stored alongside the', 'trial database, with the sponsor and held by third party vendors.', '5.4.2.2.1', 'Pre-operative Procedures', 'For prophylaxis against potential intraocular immune responses to the ATIMP, participants will be', 'prescribed a course of oral prednisolone as described in section 5.4.1.5.', 'Preoperative procedures and intraocular administration of ATIMP will be as described in the Gene', 'Therapy for Achromatopsia (CNGA3) study manual.', 'CNGA3 MGT012 Protocol version 6.0 16Apr2021', 'Page 37 of 68']\n\n###\n\n", "completion": "END"}